2016
DOI: 10.1200/jco.2016.34.15_suppl.e17015
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of safety and outcome of the combination of carboplatin (C) paclitaxel (P) and bevacizumab (B) in advanced/recurrent cervical cancer (ACC).

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles